[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-362158-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-362158-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","herv6196-as-an-enhancer-with-oncogenic-potential-in-rectal-cancer","HERV6196 as an enhancer with oncogenic potential in rectal cancer","","Colorectal cancer remains a major cause of morbidity and mortality worldwide, yet the regulatory mechanisms driving tumor development are not fully understood. This research performs locus-specific profiling of human endogenous retrovirus (HERV) gene transcripts in rectal cancer and identifies significantly dysregulated HERVs. From three Gene Expression Omnibus datasets, 25 HERVs are upregulated and 7 are downregulated. HERV6196 (HERVH) dysregulation is validated by RT-qPCR and droplet digital PCR. Functional assays show HERV6196 promotes proliferation, inhibits apoptosis, enhances colony formation and migration, and acts as an enhancer to upregulate neighboring genes, contributing to CRC progression.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/herv6196-as-an-enhancer-with-oncogenic-potential-in-rectal-cancer/362158/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/herv6196-as-an-enhancer-with-oncogenic-potential-in-rectal-cancer/362158.png","ImageObject",300,407,{"name":42,"@type":43},"Miles","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-01","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",6,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is the main focus of the study on rectal cancer?","Question",{"text":63,"@type":64},"The study investigates how dysregulated human endogenous retrovirus (HERV) gene transcripts contribute to rectal cancer progression, with emphasis on the locus HERV6196.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How were dysregulated HERVs identified and validated?",{"text":68,"@type":64},"Locus-specific profiling was performed using data from three Gene Expression Omnibus datasets to identify upregulated and downregulated HERVs. Dysregulation of HERV6196 was then validated using reverse transcription quantitative PCR and droplet digital PCR in cells and tissues.",{"name":70,"@type":61,"acceptedAnswer":71},"What effects does HERV6196 have on rectal cancer cells?",{"text":72,"@type":64},"HERV6196 promotes proliferation, inhibits apoptosis, enhances colony formation, and increases migration capability of rectal cancer cells.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},362158,1790923754,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,105,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},"Technology",50,"technology",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},7,"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},13056703019404,"https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","| Open Peer Review | Virology | Research Article  \nHERV6196 as an enhancer with oncogenic potential in rectal cancer  \nYi-Xiu Gan,1,2 Xin Jiang,3,4 Zhi-Yu Wang,1 Yi-Lin Yu,1 Ling-Dong Shao,1 Jian-Min Wang,3,4 Jun-Xin Wu1 AUTHOR AFFILIATIONS See affiliation list on p. 15.  \nABSTRACT Colorectal cancer (CRC) is among the most prevalent malignancies. However, the regulatory networks involved in tumor occurrence and development are still poorly understood. Human endogenous retroviruses (HERVs), a class of transposable elements, have been implicated in the development and progression of various human cancers. This study presents the first comprehensive locus-specific profiling of the expression of HERV gene transcripts in rectal cancer, revealing significantly dysregulated HERVs. Analysis of data from three Gene Expression Omnibus data sets revealed 25 upregulated HERVs and 7 downregulated HERVs. Dysregulation of HERV6196, a type of HERVH, was validated through reverse transcription quantitative PCR and droplet digital PCR in cells and tissues. Additionally, HERV6196 promoted the proliferation, inhibited the apoptosis, enhanced the colony formation ability, and enhanced the migration capability of rectal cancer cells. Moreover, HERV6196 functioned as an enhancer, promoting the expression of neighboring genes and the development of CRC. In summary, the present results revealed that HERV6196 is involved in the pathogenesis of rectal cancer, indicating the potential contribution of dysregulated HERVs to the development and progression of CRC through gene expression modulation.  \nIMPORTANCE The role of human endogenous retroviruses (HERVs) in colorectal cancer (CRC) remains insufficiently understood. The present study revealed aberrant expression of HERV gene transcripts in cancerous tissues compared with non-cancerous tissues. HERV6196 contributes to CRC progression by regulating the expression of neighboring genes. These findings suggest that HERVs may serve as enhancers and regulate oncogenic gene expression, providing new insights for rewiring transcriptional regulatory networks in CRC pathogenesis.  \nKEYWORDS colorectal cancer, endogenous retrovirus, dysregulated expression  \nC olorectal cancer (CRC) is a leading malignant neoplasm worldwide. According to  \nthe 2020 data of the World Health Organization, CRC is the third most common cancer in terms of incidence and the second most common in terms of mortality (1) . The majority of CRC cases arise from the gradual progression of precancerous lesions (2) . Early diagnosis and treatment of CRC are best achieved through the use of tumor markers, imaging techniques, and genetic testing, which have the potential to reduce disease morbidity and mortality (3–5) . However, current tests cannot rapidly and accurately detect CRC (6, 7). Thus, there is an urgent need to identify novel markers that can predict the occurrence of CRC.  \nHuman endogenous retroviruses (HERVs) originated 30 million years ago when exogenous retroviruses infected human ancestors. Through continuous evolution, HERVs have integrated into the human genome and become a part of it. HERVs make up approximately 8%–9% of the human genome (8–10) . A typical HERV structure consists of LTR-gag-pol-env-LTR, where the long terminal repeats (LTRs) serve as highly active  \nEditor Hyun Jin Kwun, Penn State College of Medicine, Hershey, Pennsylvania, USA  \nPeer Reviewer Michal Izydorczyk, Oxford Brookes University, Oxford, United Kingdom  \nAddress correspondence to Jian-Min Wang, [wangjm8605@163.com](wangjm8605@163.com), or Jun-Xin Wu, [junxinwufj@aliyun.com](junxinwufj@aliyun.com).  \nYi-Xiu Gan and Xin Jiang contributed equally to this article. Author order was determined alphabetically by last name.  \nauthors declare conflict of interest  \nregulatory elements for transcription (11) . HERVs are extensively distributed throughout the human body. Through genome-wide association studies, researchers have systematically identified 13,889","cbCaieHo9lip2685","https://ap.wps.com/l/cbCaieHo9lip2685","pdf",2743115,18,"English","# Abstract\n# Importance\n# Background and Rationale\n# Methods and Validation","[{\"question\":\"What is the main focus of the study on rectal cancer?\",\"answer\":\"The study investigates how dysregulated human endogenous retrovirus (HERV) gene transcripts contribute to rectal cancer progression, with emphasis on the locus HERV6196.\"},{\"question\":\"How were dysregulated HERVs identified and validated?\",\"answer\":\"Locus-specific profiling was performed using data from three Gene Expression Omnibus datasets to identify upregulated and downregulated HERVs. Dysregulation of HERV6196 was then validated using reverse transcription quantitative PCR and droplet digital PCR in cells and tissues.\"},{\"question\":\"What effects does HERV6196 have on rectal cancer cells?\",\"answer\":\"HERV6196 promotes proliferation, inhibits apoptosis, enhances colony formation, and increases migration capability of rectal cancer cells.\"}]","HERV6196 as an enhancer with oncogenic potential in rectal cancer | PDF",1790146612,45,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f8e0337892626a33b10e3b080c355f75.webp",983,1315,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/df471466274e49154ba1631c9fcdc72e.webp",982,1314,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4ae94c64146e5fcb3c777af8cde93dc8.webp",981,1312,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/01a4febc30898f66ca9b68af04a184df.webp",980,1311]